Tech Company Financing Transactions
Vascular Pharmaceuticals Funding Round
Vascular Pharmaceuticals, based in Research Triangle Park, secured $9 million in investment from private investors.
Transaction Overview
Company Name
Announced On
3/4/2015
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series A
Investors
Proceeds Purpose
The financing will enable it to better compete for study participants for its midstage clinical trial of a drug for diabetic nephropathy.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
79 TW Alexander Dr. Research Commons 4401-200A
Research Triangle Park, NC 27517
USA
Research Triangle Park, NC 27517
USA
Phone
Website
Email Address
Overview
Vascular Pharmaceuticals, Inc. is focused on the development and commercialization of novel therapeutics targeting the treatment of diabetes associated complications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Shea
Chief Financial Officer
Bonnie Layman
Chief Scientific Officer
David Clemmons
VP - R & D
Laura Maile
Browse more venture capital transactions:
Prev: 3/4/2015: Metric Insights venture capital transaction
Next: 3/4/2015: Renmatix venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs